The production of IL-6, capable of promoting tumor growth, was found to be increased in lymph node cells from tumor-bearing mice stimulated with CD3/CD28 antibodies compared to non-tumor-bearing mice in both LY2 and MOC2 HNSCC models (Figure 5D). Here, CD28 is linked to neoplasm.